225
Views
3
CrossRef citations to date
0
Altmetric
Editorials

In pursuit of the normal progressor: the holy grail for ALS clinical trial design?

&
Pages 1-2 | Received 29 Aug 2019, Accepted 16 Sep 2019, Published online: 11 Oct 2019
 
This article is related to:
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

Data availability statement

The data that support the findings of this study are openly available in PRO-ACT at https://nctu.partners.org/ProACT, version December 2015.

Declaration of interest

The authors declare that they have no conflict of interest.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 478.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.